Interview: Post-FDA, Williams Still Committed To Supplement GMPs
This article was originally published in The Tan Sheet
Executive Summary
Brad Williams has moved on from FDA’s Division of Dietary Supplement Programs, but he continues to drive industry GMP compliance at NSF International. In an interview, Williams relates what the industry must do to overcome GMP struggles and commends Dan Fabricant’s work as DDSP director.
You may also be interested in...
Supplement Firms Should Work Toward Sharing GMP Audits – FDA's Williams
FDA dietary supplement program official Brad Williams personally endorses the sharing of supplier audit reports to improve firms' compliance with good manufacturing practices.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.